PSMA-11 PET/CT for Detection of Recurrent Prostate Cancer in Patients With Negative Choline PET/CT.
(18)F-Choline
(68)Ga-PSMA-11
Biochemical recurrence
Positron emission tomography/computed tomography (PET/CT)
Prostate cancer
Journal
Clinical genitourinary cancer
ISSN: 1938-0682
Titre abrégé: Clin Genitourin Cancer
Pays: United States
ID NLM: 101260955
Informations de publication
Date de publication:
04 2023
04 2023
Historique:
received:
13
05
2022
revised:
21
12
2022
accepted:
24
12
2022
medline:
28
3
2023
pubmed:
20
1
2023
entrez:
19
1
2023
Statut:
ppublish
Résumé
Prostate adenocarcinoma (CaP) is the leading cancer in men. After curative treatment, from 27% to 53% of patients will experience biochemical recurrence (BR). With the development of focal therapies, precise early identification of recurrence's sites is of utmost importance in order to deliver individualized treatment on positive lesions. The aim of this study was to assess the detection rate (DR) of We performed a retrospective analysis including all patients with CaP referred for BR with a negative One hundred fifty-nine patients comprising 164 examinations were analyzed. The overall DR of Our study confirmed the ability of
Identifiants
pubmed: 36658064
pii: S1558-7673(22)00265-8
doi: 10.1016/j.clgc.2022.12.007
pii:
doi:
Substances chimiques
gallium 68 PSMA-11
0
Prostate-Specific Antigen
EC 3.4.21.77
Androgen Antagonists
0
Choline
N91BDP6H0X
Gallium Radioisotopes
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
248-257Informations de copyright
Copyright © 2022 Elsevier Inc. All rights reserved.